,,ii  #aafth ,,congress  #b;d ,session  
,s4 #cfce  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,may #f1       
#bjbj,mr4 ,cotton 7for himself1 ,mrs4   
,blackburn1 ,mr4 ,cruz1 ,mr4 ,daines1   
and ,mr4 ,scott of ,florida7 introduced 
the following bill2 which was read twice
 and referred to the ,committee on      
,finance  ,a ,,bill  ,to require the    
,secretary of ,health and ,human        
,services to maintain a list of the     
country of origin of all drugs marketed 
in the ,united ,states1 to ban the use  
of ,federal funds for the purchase of1  
or reimbursement for1 drugs manufactured
 in ,china1 and for other purposes4  #a4
 ,short title ,this ,act may be cited as
 the ,protecting ,our ,pharmaceutical   
,supply ,chain from ,china ,act of      
#bjbj4  #b4 ,country of origin of drugs 
7a7 ,in general ,subchapter ,a of       
chapter ,v of the ,federal ,food1 ,drug1
 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cea 
et seq47 is amended by adding at the end
 the following3  #ebd;,b4 ,registry of  

drugs produced outside the ,united      
,states  7a7 ,in general ,the ,secretary
 shall compile and maintain a list of   
all drugs approved under subsection 7c7 
or 7j7 of section #eje of this ,act or  
licensed under subsection 7a7 or 7k7 of 
section #cea of the ,public ,health     
,service ,act1 and any active           
ingredients in such drugs1 that-- 7#a7  
are manufactured outside of the ,united 
,states2 and  7#b7 are determined by the
 ,secretary to be critical to the health
 and safety of consumers in the ,united 
,states4  7b7 ,additional list ,in      
conjunction with the list described in  
subsection 7a71 the ,secretary shall    
compile and maintain a list of drugs    
included on such list that are          
exclusively produced in1 or use active  
or inactive ingredients produced in1 the
 ,people's ,republic of ,china4  7c7    
,requirement ,the list described in     
subsection 7a7 shall1 with respect to   
each drug included on the list1 provide 
information about the drug's supply     

chain1 including each step in the supply
 chain that occurs prior to the drug's  
importation into the ,united ,states4  4
  7b7 ,federal health program purchase  
of1 or reimbursement for1 drugs  7#a7   
,in general ,notwithstanding any other  
provision of law1 the ,department of    
,health and ,human ,services1 the       
,department of ,veterans ,affairs1 the  
,department of ,defense1 and any other  
,federal health care program 7as defined
 in section #aabh;,b7f7 of the ,social  
,security ,act 7#db ,u4,s4,c4           
#acbj;a-#g;b7b771 with respect to the   
purchase of1 or reimbursement for1 a    
drug by such agency or program1 the     
following shall apply3 7,a7 ,by #bjbb1 a
 purchaser of1 or reimbursor for1 drugs 
described in this subsection shall      
purchase drugs or reimburse for drugs   
only if such drugs contain #fj percent  
or more of their active pharmaceutical  
ingredients manufactured in countries-- 
7i7 other than the ,people's ,republic  
of ,china2 and  7ii7 that meet the ,food

 and ,drug ,administration's health and 
safety standards4  7,b7 ,by #bjbc1 a    
purchaser of1 or reimbursor for1 drugs  
described in this subsection shall      
purchase drugs or reimburse for drugs   
only if such drugs contain #ajj percent 
of their active pharmaceutical          
ingredients manufactured in countries-- 
7i7 other than the ,people's ,republic  
of ,china2 and  7ii7 that meet the ,food
 and ,drug ,administration's health and 
safety standards4  7#b7 ,waivers ,the   
,secretary of ,health and ,human        
,services may issue waivers of the      
requirements under paragraph 7#a7 for   
any agency or program that is unable to 
meet such requirements and demonstrates 
a need for the waiver4 ,no waiver may be
 issued under this paragraph for drugs  
that are purchased on or after ,january 
#a1 #bjbe4  7c7 ,labeling requirement   
,section #ejb of the ,federal ,food1    
,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4
 #ceb7 is amended by adding at the end  
the following3  7ee7 ,if it is a drug   

and its labeling does not specify the   
country of origin of each active        
ingredient contained in the drug4  4    
#c4 ,temporary #ajj percent expensing   
for pharmaceutical and medical device   
manufacturing property  7a7 ,in general 
,for purposes of section #afh7k7 of the 
,internal ,revenue ,code of #aihf1 in   
the case of any qualified pharmaceutical
 and medical device manufacturing       
property which is placed in service     
after ,december #ca1 #bjai1 and before  
,january #a1 #bjbf-- 7#a7 such property 
shall be treated as qualified property  
7within the meaning of such section71   
7#b7 the applicable percentage otherwise
 determined under section #afh7k77#f7 of
 such ,code with respect to such        
property shall be #ajj percent1 and     
7#c7 paragraph 7#h7 of such section     
shall not apply4  7b7 ,qualified        
pharmaceutical and medical device       
manufacturing property ,for purposes of 
this section1 the term qualified        
pharmaceutical and medical device       

manufacturing property means any        
tangible property placed in service in  
the ,united ,states as part of the      
construction or expansion of property   
for the manufacture of drugs 7as defined
 in section #bja7;g7 of the ,federal    
,food1 ,drug1 and ,cosmetic ,act 7#ba   
,u4,s4,c4 #cba7;g777 or medical devices 
7as defined in section #bja7;h7 of such 
,act 7#ba ,u4,s4,c4 #cba7;h7774  7c7    
,termination ,this section shall not    
apply to any property placed in service 
after ,december #ca1 #bjbe4  #d4 ,rule  
of construction ,nothing in this ,act   
shall be construed to divert the        
resources of the ,food and ,drug        
,administration from responding to the  
,,covid-#ai public health emergency4